SNOT-22 questionnaire predicts ANCA-associated vasculitis relapse risk up to 2 years
Higher scores on a measure of sinonasal symptoms can predict ANCA-associated vasculitis relapse “months to years” ahead of time, according data published in Arthritis Care & Research. The 22-item Sinonasal Outcome Test (SNOT-22) could enhance prediction of relapse among high-risk patients and may be useful in selectively escalating or de-escalating immunosuppressive therapy, Ellen